Target intelligence / Profile preview

NAA20 pseudogene 1 (NAA20P1)

Target
NAA20P1
Molecular classification
Other
01

Overview

NAA20P1 is a pseudogene of the human NAA20 (N-alpha-acetyltransferase 20, NatB catalytic subunit) gene[2]. It does not encode a functional protein. Pseudogenes are non-functional DNA segments that resemble known genes but typically lack biological activity due to disabling mutations or loss of regulatory elements. While the functional NAA20 gene is a catalytic component of the NatB N-terminal acetyltransferase complex involved in N-terminal acetylation of proteins, NAA20P1 lacks evidence of being translated or functioning as a therapeutic target[2]. There is no current evidence linking NAA20P1 to disease mechanisms, drug interactions, or use as a biomarker. As a pseudogene, it should not be considered a classical molecular target for therapeutics. Note: If you are seeking information on the active enzyme, refer to N-alpha-acetyltransferase 20, NatB catalytic subunit (NAA20). The pseudogene (NAA20P1) itself is not a drug target and has no defined molecular or clinical functions. This entry is marked is_incorrect: true because pseudogenes like NAA20P1 do not code for a functional product and are not exploited directly in drug discovery or biology as active targets[2].

Other names
NAA20P1NAA20 pseudogene 1

Beyond the preview

Go deeper on NAA20 pseudogene 1 (NAA20P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NAA20 pseudogene 1 (NAA20P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call